- « Previous
- Clinical Pharmacology
- Next »
Rescriptor
Clinical Pharmacology
Rescriptor
↑Indicates increase
¯ Indicates decrease
« INDICATES NO SIGNIFICANT CHANGE
* RELATIVE TO INDINAVIR 800 MG TID WITHOUT RESCRIPTOR
† Plasma concentrations of the nelfinavir active metabolite (nelfinavir hydroxy-t-butylamide) were significantly reduced by delavirdine, which is more than compensated for by increased nelfinavir concentration
† SAQUINAVIR SOFT GEL CAPSULE 1000 MG TID PLUS RESCRIPTOR 400 MG TID RELATIVE TO SAQUINAVIR SOFT GEL CAPSULE 1200 MG TID WITHOUT RESCRIPTOR
§ RESCRIPTOR taken with didanosine (buffered tablets) relative to doses of RESCRIPTOR and didanosine (buffered tablets) separated by at least 1 hr - Indicates no data available
Table 2. Pharmacokinetic Parameters for Delavirdine in the Presence of Coadministered Drugs
| Coadministered Drug | Dose of Coadministered Drug | Dose of RESCRIPTOR | n | % Change in Delavirdine Pharmacokinetic Parameters (90% CI) | ||
| Cmax | AUC | Cmin | ||||
| HIV-Protease Inhibitors | ||||||
| Indinavir | 400 or 600 mg tid ×7 days | 400 mg tid × 7 days | 81 | No apparent changes based on a comparison to historical data | ||
| Nelfinavir | 750 mg tid × 7 days | 400 mg tid × 14 days | 7 |
¯27 (¯49-↑4) |
¯31 (¯57-↑10) |
¯33 (¯70-↑49) |
| Saquinavir | Soft gel capsule 1000 mg tid × 28 days | 400 mg tid for 7-28 days | 23 | No apparent changes based on a comparison to historical data | ||
| Nucleoside Reverse Transcriptase Inhibitors | ||||||
| Didanosine (buffered tablets) | 125 or 200 mg bid
x 28 days | 400 mg tid x 28 days | 9 |
¯32* (¯48-¯11) |
¯19* (¯37-↑6) |
«* |
| Zidovudine | 200 mg tid for ≥ 7 days | 400 mg tid for 7-14 days | 42 | No apparent changes based on a comparison to historical data | ||
| Anti-infective Agents | ||||||
| Clarithromycin | 500 mg bid
x 15 days | 300 mg tid
x 30 days | 6 |
« |
« |
« |
| Fluconazole | 400 mg qd
x 15 days | 300 mg tid
x 30 days | 8 |
« |
« |
« |
| Ketoconazole | Various | 200-400 mg tid | 26 | - | - |
↑50† |
| Rifabutin | 300 mg qd
x 14 days | 400 mg tid
x 28 days | 7 |
¯72 (¯61-¯80) |
¯82 (¯74-¯88) |
¯94 (¯90-¯96) |
| Rifampin | 600 mg qd
x 15 days | 400 mg tid
x 30 days | 7 |
¯90 (¯94-¯83) |
¯97 (¯98-¯95) |
¯100 |
| Sulfamethoxazole or Trimethoprim & Sulfamethoxazole | Various | 200-400 mg tid | 311 | - | - |
Ǡ |
| Other | ||||||
| Antacid (MaaloxÒ TC) | 20 mL | 300 mg single dose | 12 |
¯52 (¯68-¯29) |
¯44 (¯58-¯27) | - |
| Fluoxetine | Various | 200-400 mg tid | 36 | - | - |
↑50† |
| Phenytoin, Phenobarbital, Carbamazepine | Various | 300-400 mg tid | 8 | - | - |
¯90† |
Generic Name: Delavirdine Mesylate
- « Previous
- Clinical Pharmacology
- Next »
HIV Test for Early Detection
There is a test that may help detect the virus sooner, so patients can start treatment much faster. See more WebMD Videos »
WebMD Daily
Get breaking medical news.
